M A. Sherif

M A. Sherif

Auto-generated profile, based on publicly available information

M A. Sherif

University College London, Institute of Child Health, Developmental Endocrinology Research Group, Clinical and Molecular Genetics Unit, London, United Kingdom

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2021 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
PDF file
MSMaha Sherif
Maha Sherif
HDHuseyin Demirbilek
Huseyin Demirbilek
ACAtilla Cayir
Atilla Cayir
STSophia Tahir
Sophia Tahir
CCCavdarli Cavdarli
Cavdarli Cavdarli
KHKhalid Hussain
Khalid Hussain
Bi-allelic mutations in the wolframin gene (WFS1) cause Wolfram syndrome 1 (WS1 or DIDMOAD) characterized by non-autoimmune diabetes mellitus, optic atrophy, diabetes insipidus, sensorineural deafness, urinary tract abnormalities, and neuropsychiatric disorders. Patients presenting with an incomplete phenotype of WS1 were evaluated using homozygosity mapping and subsequent whole-exome sequencing. Four unrelated consanguineous Turkish families, including seven affected children, and their unaffected parents and siblings were evaluated. Homozygosity mapping was performed, followed by whole-exome sequencing of WFS1. Mutations were classified according to results of “in silico” analyses, protein prediction, and functional consequences. Homozygosity mapping confirmed shared homozygous regions on chromosome 4 (chr4p16.1) between the affected individuals, that was absent in their unaffected siblings. Exome sequencing identified three novel (c.1215T>A, c.554G>A, c.1525_1540dup) and one known (c.1522_1523delTA) mutations in WFS1. All mutations were predicted to cause stop codon leading to early termination of protein synthesis and complete loss-of-function. All patients were found to be homozygous for the change, with parents and other unaffected siblings being carriers. Our study expands the mutation spectrum of WSF1 mutations with three novel mutations. Homozygosity mapping may provide enrichment for molecular genetic analysis and early diagnosis of WS1 patients with incomplete phenotype, particularly in consanguineous pedigrees.

1 October 2013 in Journal of Animal and Poultry Production
Verified
Journal Article
Open access
PDF file
AAabdel-khalek abdel-khalek
abdel-khalek abdel-khalek
AMA. F. Mehrez
A. F. Mehrez
MSM A. Sherif
M A. Sherif
To establish the effect of daily oral treatment with different levels of L-Carnitine (LC) for 3 mo on body weight, blood parameters and reproductive performance of Friesian bulls, total of 9 bulls (360±32.1 kg LBW and 20±1.4 mo of age) were assigned into 3 groups. All bulls were fed the same diet and kept under the same condition, but differed in LC treatment. Bulls were received oral dose of LC for 3 mo at levels of 0, 1 and 2 g/h/d in G1, G2 and G3, respectively. At the end of treatment, semen was collected from bulls twice a week for 12 wk and evaluated for ejaculate volume,sperm motility, sperm livability, sperm cell concentration and total sperm output. At the end of semen collection, blood samples were collected from all animals for determination of total protein (TP), albumin (AL), globulin (GL), urea-N, cholesterol (CHO), glucose and total lipids (TL) concentration and activity of AST and ALT in blood serum. Also, testosterone concentration was determined in blood serum after 1 and 3 mo of treatment. Results show that bulls in G3 showed the heaviest weights and gain as compared to G1, but did not differ significantly from those in G2. In blood serum of bulls, concentration of TP and GL increased (P<0.05), while AL/GL ratio and concentration of CHO and TL reduced (P<0.05) in G2 and G3 as compared to G1. Concentration of AL, glucose and urea-N or activity of AST and ALT were not affected by LC treatment. All semen characteristics of bulls improved (P<0.05)in G2 and G3 as compared to G1, being better (P<0.05) in G3 than in G2 for most characteristics. Serum testosterone concentration was higher (P<0.05) in G2 and G3 than in G1. In conclusion, oral dose of LC at a level of 2 g/h/d for 3 mo had impact to achieve high quality semen to spread the use of artificial insemination with bulls of high fertility.